BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37997519)

  • 1. Metformin reduces hepatocarcinogenesis by inducing downregulation of Cyp26a1 and CD8
    He W; Wang X; Chen M; Li C; Chen W; Pan L; Cui Y; Yu Z; Wu G; Yang Y; Xu M; Dong Z; Ma K; Wang J; He Z
    Clin Transl Med; 2023 Nov; 13(11):e1465. PubMed ID: 37997519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells.
    Ozpolat B; Mehta K; Lopez-Berestein G
    Leuk Lymphoma; 2005 Oct; 46(10):1497-506. PubMed ID: 16194896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of NADPH-cytochrome P450 reductase on all-trans-retinoic acid efficacy and cytochrome P450 26A1 expression in human myeloid leukaemia HL-60 cells.
    Hu L; Lv JF; Zhuo W; Zhang CM; Zhou HH; Fan L
    J Pharm Pharmacol; 2016 Sep; 68(9):1193-202. PubMed ID: 27366899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
    Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
    Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The retinoic acid hydroxylase Cyp26a1 has minor effects on postnatal vitamin A homeostasis, but is required for exogenous
    Zhong G; Hogarth C; Snyder JM; Palau L; Topping T; Huang W; Czuba LC; LaFrance J; Ghiaur G; Isoherranen N
    J Biol Chem; 2019 Jul; 294(29):11166-11179. PubMed ID: 31167781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and clinical implications of retinoic acid-responsive genes in human hepatocellular carcinoma cells.
    Kanki K; Akechi Y; Ueda C; Tsuchiya H; Shimizu H; Ishijima N; Toriguchi K; Hatano E; Endo K; Hirooka Y; Shiota G
    J Hepatol; 2013 Nov; 59(5):1037-44. PubMed ID: 23831118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of AMP-activated protein kinase by retinoic acid sensitizes hepatocellular carcinoma cells to apoptosis induced by sorafenib.
    Ishijima N; Kanki K; Shimizu H; Shiota G
    Cancer Sci; 2015 May; 106(5):567-75. PubMed ID: 25683251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27
    Tuo L; Xiang J; Pan X; Hu J; Tang H; Liang L; Xia J; Hu Y; Zhang W; Huang A; Wang K; Tang N
    J Exp Clin Cancer Res; 2019 Feb; 38(1):50. PubMed ID: 30717766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normalizing Microbiota-Induced Retinoic Acid Deficiency Stimulates Protective CD8(+) T Cell-Mediated Immunity in Colorectal Cancer.
    Bhattacharya N; Yuan R; Prestwood TR; Penny HL; DiMaio MA; Reticker-Flynn NE; Krois CR; Kenkel JA; Pham TD; Carmi Y; Tolentino L; Choi O; Hulett R; Wang J; Winer DA; Napoli JL; Engleman EG
    Immunity; 2016 Sep; 45(3):641-655. PubMed ID: 27590114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All-trans retinoic acid protects hepatocellular carcinoma cells against serum-starvation-induced cell death by upregulating collagen 8A2.
    Wang W; Xu G; Ding CL; Zhao LJ; Zhao P; Ren H; Qi ZT
    FEBS J; 2013 Mar; 280(5):1308-19. PubMed ID: 23298258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose metformin suppresses hepatocellular carcinoma metastasis via the AMPK/JNK/IL-8 pathway.
    Zhao C; Zheng L; Ma Y; Zhang Y; Yue C; Gu F; Niu G; Chen Y
    Int J Immunopathol Pharmacol; 2024; 38():3946320241249445. PubMed ID: 38679570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of CYP26A1 by metabolites of retinoic acid: evidence that CYP26A1 is an important enzyme in the elimination of active retinoids.
    Topletz AR; Tripathy S; Foti RS; Shimshoni JA; Nelson WL; Isoherranen N
    Mol Pharmacol; 2015; 87(3):430-41. PubMed ID: 25492813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative regulation of Sirtuin 1 by AMP-activated protein kinase promotes metformin-induced senescence in hepatocellular carcinoma xenografts.
    Zhou X; Chen J; Chen L; Feng X; Liu Z; Hu L; Zeng Z; Jia X; Liang M; Shi B; Yi G; Liu J
    Cancer Lett; 2017 Dec; 411():1-11. PubMed ID: 28964787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin and AICAR regulate NANOG expression via the JNK pathway in HepG2 cells independently of AMPK.
    Shen C; Ka SO; Kim SJ; Kim JH; Park BH; Park JH
    Tumour Biol; 2016 Aug; 37(8):11199-208. PubMed ID: 26939902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin and glucose starvation decrease the migratory ability of hepatocellular carcinoma cells: targeting AMPK activation to control migration.
    Ferretti AC; Hidalgo F; Tonucci FM; Almada E; Pariani A; Larocca MC; Favre C
    Sci Rep; 2019 Feb; 9(1):2815. PubMed ID: 30809021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRABPs Alter
    Yabut KCB; Isoherranen N
    Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancer.
    Zhang Y; Guan DX; Shi J; Gao H; Li JJ; Zhao JS; Qiu L; Liu J; Li N; Guo WX; Xue J; Zhou FG; Wu MC; Wang HY; Xie D; Cheng SQ
    J Hepatol; 2013 Dec; 59(6):1255-63. PubMed ID: 23867314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting AMPK, mTOR and β-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients.
    Abdelmonsif DA; Sultan AS; El-Hadidy WF; Abdallah DM
    Mol Diagn Ther; 2018 Feb; 22(1):115-127. PubMed ID: 29094287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo.
    Cai X; Hu X; Cai B; Wang Q; Li Y; Tan X; Hu H; Chen X; Huang J; Cheng J; Jing X
    Oncol Rep; 2013 Nov; 30(5):2449-57. PubMed ID: 24008375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma.
    Lin L; Chen S; Wang H; Gao B; Kallakury B; Bhuvaneshwar K; Cahn K; Gusev Y; Wang X; Wu Y; Marshall JL; Zhi X; He AR
    Theranostics; 2021; 11(9):4232-4250. PubMed ID: 33754058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.